Cargando…

Efficacy and safety of omalizumab therapy in urticaria vasculitis

Urticarial vasculitis (UV) is a small-vessel leukocytoclastic vasculitis characterized by different clinical manifestations ranging from long-lasting urticarial lesions to severe and potentially life-threatening multi-organ involvement. Omalizumab (OMA), anti-IgE recombinant humanized IgG1 monoclona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrelli, Fiorella, Giannini, Daiana, Bilia, Silvia, Del Corso, Isabella, Rocchi, Valeria, Migliorini, Paola, Puxeddu, Ilaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353047/ https://www.ncbi.nlm.nih.gov/pubmed/35935020 http://dx.doi.org/10.3389/falgy.2022.952079

Ejemplares similares

Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications
por: Puxeddu, Ilaria, et al.
Publicado: (2019)

Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
por: García-Gómez, Elizabeth, et al.
Publicado: (2022)

274 Vasculitic Urticaria Treated with Omalizumab. Case Report
por: Ramírez Del Pozo, María Elena, et al.
Publicado: (2012)

275 Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report
por: Varricchi, Gilda, et al.
Publicado: (2012)

269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012)

The Role of Skin Tests in the Prevention and Diagnosis of Hypersensitivity Reactions to Platinum Agents in Gynecological Cancer: A Single-Center Italian Retrospective Study
por: Puxeddu, Ilaria, et al.
Publicado: (2021)

Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
por: Song, Xiaoting, et al.
Publicado: (2023)

Urticaria and mimickers of urticaria
por: Fok, Jie Shen, et al.
Publicado: (2023)

A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real‐world study in Belgium
por: Lapeere, H., et al.
Publicado: (2019)

281 Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic
por: Correa, Jorge Vargas
Publicado: (2012)

Urticaria in Pregnancy and Lactation
por: Kocatürk, Emek, et al.
Publicado: (2022)

Editorial: The complexity of urticaria
por: Makris, Michael, et al.
Publicado: (2023)

Safety Evaluation of an Expedited Omalizumab Home Self-Administration Pathway
por: Hussain, Zobia, et al.
Publicado: (2021)

The many faces of pediatric urticaria
por: Sekerel, Bulent Enis, et al.
Publicado: (2023)

Therapeutic efficacy of omalizumab in children with moderate-to-severe allergic asthma combined with chronic sinusitis
por: Chong, Weikun, et al.
Publicado: (2023)

Chronic Urticaria: The Need for Improved Definition
por: Gómez, R. Maximiliano, et al.
Publicado: (2022)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Mediators of Inflammation and Angiogenesis in Chronic Spontaneous Urticaria: Are They Potential Biomarkers of the Disease?
por: Puxeddu, Ilaria, et al.
Publicado: (2017)

Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management
por: Ensina, Luis Felipe, et al.
Publicado: (2022)

Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016)

Comorbidities of Chronic Urticaria: A glimpse into a complex relationship
por: Papapostolou, Niki, et al.
Publicado: (2022)

Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
por: Mobayed, Hassan, et al.
Publicado: (2023)

Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
por: Haddad, Isabelle, et al.
Publicado: (2022)

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients
por: Dekkers, Coco, et al.
Publicado: (2021)

Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries
por: Altrichter, Sabine, et al.
Publicado: (2022)

Urticaria and angioedema as possible reactions of omalizumab
por: Ozbagcivan, Ozlem, et al.
Publicado: (2018)

Efficacy and safety of omalizumab in Chinese patients with anti‐histamine refractory chronic spontaneous urticaria
por: Yuan, Weiru, et al.
Publicado: (2022)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

Incapacitating solar urticaria: successful treatment with omalizumab
por: Kieselova, Katarina, et al.
Publicado: (2019)

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China()
por: Wang, Ao, et al.
Publicado: (2022)

T cell activity in successful treatment of chronic urticaria with omalizumab
por: Sánchez-Machín, Inmaculada, et al.
Publicado: (2011)

Omalizumab therapy in three patients with chronic autoimmune urticaria
por: Al-Ahmad, Mona
Publicado: (2010)

Effects of Omalizumab Treatment in Patients With Refractory Chronic Urticaria
por: Nam, Young-Hee, et al.
Publicado: (2012)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
por: Hébert, Jacques, et al.
Publicado: (2012)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Expert consensus on the use of omalizumab in chronic urticaria in China()
por: Zhao, Zuotao, et al.
Publicado: (2021)

279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ihgmt10g3jl4pma2dmq61cojje